Finance

Beta
Lists
000250:KOSDAQ
Sam Chun Dang Pharm Co Ltd
₩292,000.00
-5.65%
(-17,500.00) 1D
Jun 5, 3:30:21 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000250...
Open
₩312,000
High
₩315,000
Low
₩290,000
Mkt. cap
6.85T
Avg. vol.
248.82K
Volume
141.11K
Dividend
0.02%
Quarterly dividend
₩13
Ex-dividend date
Dec 29, 2025
P/E ratio
665.41
52-wk high
₩1,233,000
52-wk low
₩140,000
EPS
₩439
Shares outstanding
23.46M
No. of employees
422
Open
₩312,000
High
₩315,000
Low
₩290,000
Mkt. cap
6.85T
Avg. vol.
248.82K
Volume
141.11K
Dividend
0.02%
Quarterly dividend
₩13
Ex-dividend date
Dec 29, 2025
P/E ratio
665.41
52-wk high
₩1,233,000
52-wk low
₩140,000
EPS
₩439
Shares outstanding
23.46M
No. of employees
422
News stories
From sources across the web
About Sam Chun Dang Pharm Co Ltd
CEO-
Employees422
Founded1943
Headquarters-
SectorPharmaceutical industry
Websitescd.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
56.90B
58.02B
66.26B
64.87B
Cost of goods sold
31.08B
30.97B
34.78B
33.09B
Cost of revenue
31.08B
30.97B
34.78B
33.09B
Research and development expenses
4.57B
1.01B
1.73B
1.64B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.78B
21.94B
22.60B
23.18B
Operating expense
26.90B
23.62B
26.10B
26.33B
Total operating expenses
57.98B
54.59B
60.88B
59.42B
Operating income
-1.08B
3.43B
5.38B
5.45B
Other non operating income
-18.18M
-24.66M
439.40M
34.98M
EBT including unusual items
-1.72B
5.25B
7.43B
8.43B
EBT excluding unusual items
-1.89B
4.71B
7.33B
7.23B
Income tax expense
-105.64M
789.23M
-474.71M
1.53B
Effective tax rate
6.14%
15.03%
-6.39%
18.12%
Other operating expenses
260.81M
387.28M
397.92M
323.16M
Net income
-3.34B
2.57B
5.55B
5.45B
Net profit margin
-5.86%
4.43%
8.37%
8.40%
Earnings per share
-
-
-
-
Interest and investment income
1.08B
722.65M
761.78M
612.21M
Interest expense
-
-589.76M
-61.72M
-491.90M
Net interest expenses
1.08B
132.89M
700.06M
120.30M
Depreciation and amortization charges
694.32M
707.10M
709.38M
718.63M
EBITDA
2.00B
5.68B
8.58B
8.64B
Gain or loss from assets sale
-32.70M
37.77M
-440.92M
-35.54M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer